PICK A TIME SLOT
₹ Price not available
₹
You will receive an SMS with a verification code on this number.
Are you new to hospital ?
We have sent you an OTP on
Resend OTP
Did not receive OTP? You can request for another OTP. Click on Resend OTP
Go Back
Your appointment is
confirmed.
The details will be shared via Email & SMS
Note :Temporary visitor restriction, only one attendant is permitted with the patient. Your cooperation is solicited.
Dr. Debdeep Samaddar is an esteemed consultant at the Department of Medical Oncology at Manipal Hospital EM Bypass, Kolkata. With a distinguished academic background of MBBS from College of Medicine and Sagar Dutta Hospital, Kolkata, MD in Radiation Oncology from R.G. Kar Medical College and Hospital, Kolkata, and DM in Medical Oncology from Tata Memorial Hospital, Mumbai, Dr. Debdeep Samaddar’s clinical practice focuses on evidence-based oncology care, personalised treatment planning, and a multidisciplinary approach for the comprehensive management of cancer.
Over the course of his practice, Dr. Debdeep Samaddar has remained associated with reputed medical establishments across the country, which further strengthened his skill set in cancer diagnosis, treatment and management through structured and compassionate cancer care for patients across different stages of the disease. He specialises in the treatment and management of a wide spectrum of cancers in sub-specialities encompassing Hemato-Oncology, GI Oncology, Breast Oncology, Uro Oncology, Thoracic Oncology, and Bone & Soft Tissue Oncology. His areas of clinical and academic interest include genitourinary malignancies, plasma cell dyscrasias, sarcomas, and immuno-oncology. His dual exposure to medical oncology and radiation oncology helps him contribute effectively through multimodal treatment approaches, which include chemotherapy, immunotherapy, targeted therapy, supportive care, and patient counselling.
Beyond his clinical acumen, Dr. Debdeep Samaddar has a strong interest in oncology research, medical writing, and academic communication. He is dedicated towards contributing to advancements in medical science, and his contributions include multiple peer-reviewed publications, abstracts, poster presentations, and oral presentations at national and international oncology forums. Dr. Samaddar is also passionate about community health education and cancer awareness. Through patient education and counselling, he aims to help people understand warning symptoms, risk factors, screening importance, available treatment options, and the value of regular follow-up.
With a practice representing a balanced combination of advanced oncology training, multidisciplinary care, research orientation, and compassionate patient support, Dr. Debdeep Samaddar aims to provide comprehensive cancer care which aligns with each patient’s medical needs and treatment goals.
- Genitourinary malignancies
- Plasma cell dyscrasias
- Sarcomas
- Breast Oncology
- Immuno-oncology
- English
- Hindi
- Bengali
- Advanced oncology training from Tata Memorial Hospital, Mumbai, one of India’s leading cancer care and research institutes.
- Worked as Medical Oncologist / Ad hoc Assistant Professor at Tata Memorial Hospital, Mumbai from May 2025 to April 2026.
- Experienced in managing a wide range of cancer patients, including solid tumours, blood cancers, genitourinary cancers, plasma cell disorders, sarcomas, and thoracic malignancies.
- Actively participated in multidisciplinary tumour board meetings, contributing to treatment planning and evaluation of complex cancer cases.
- Strong academic orientation in genitourinary malignancies, plasma cell dyscrasias, sarcomas, and immuno-oncology.
- Presented research at national and international oncology conferences, including ESMO Asia, International Myeloma Society Annual Conference, Indian Myeloma Congress, ICON, and ESMO Rare Tumor and Sarcoma Congress.
- Contributed to real-world and retrospective oncology outcomes research, with multiple abstracts, posters, mini oral presentations, and peer-reviewed publications.
- Completed Clinical Research Methods and Protocol Development Workshop – AAZPIRE 2024, Mumbai.
- Completed ACLS and BLS workshop at ACTREC, Mumbai.
- Incidence and clinical profile of brain metastasis treated with whole brain radiotherapy in a tertiary hospital in eastern India: A retrospective audit, Indian Journal of Cancer, 2023.
- Is active surveillance a good treatment option for stage 1 seminoma in a developing nation? Long-term outcomes from the Indian subcontinent eCancer, 2025.
- Perception of Oncology Evaluated by Medical Students — P.O.E.M.S.: A Single Institutional Study Journal of Cancer Education, 2022.
- Genomic Profiling of Driver Gene Alterations in Patients With Non-Small Cell Lung Cancer, Patterns of Treatment and Impact on Survival Outcomes: A Single Centre Experience of More Than 1200 Patients, Clinical Lung Cancer, 2025.
- Docetaxel-oxaliplatin-capecitabine/5-fluorouracil followed by docetaxel versus oxaliplatin-capecitabine/5-fluorouracil in HER2-negative advanced gastric cancers, JNCI Cancer Spectrum, 2024.
- The utility of tumour markers in detecting relapses in testicular seminoma: largest experience from a comprehensive cancer centre in India.
- Annals of Oncology, 2024.
- Clinical profile, treatment patterns, outcomes and predictors of survival in AL amyloidosis: A retrospective study from a tertiary cancer centre, Clinical Lymphoma Myeloma Leukaemia, 2025.
- Clinical outcomes and prognostic determinants in relapsed Ewing sarcoma: Real-world experience from Indian subcontinent ESMO Rare Cancers. Poster presentation at ESMO Asia 2024, Singapore
- Topic: The utility of tumour markers in detecting relapses in testicular seminoma.
- Poster presentation at International Myeloma Society Annual Conference 2025, Toronto, Canada
- Topic: Clinical profile, treatment patterns, outcomes and predictors of survival in AL amyloidosis.
- Mini Oral Presentation at Indian Myeloma Congress 2025, Kolkata
- Topic: Clinical profile and outcome of primary refractory disease in multiple myeloma.
- Mini Oral Presentation at ICON 2024, Mumbai
- Topic: Incidence, treatment pattern and clinical outcomes of acute myeloid leukaemia patients.
- Mini Oral Presentation at Indian Myeloma Congress 2026, Kochi
- Topic: Correlation of haematological response with outcome in AL amyloidosis.
- Poster presentation at ESMO Rare Tumor and Sarcoma Congress 2026, Lugano, Switzerland
- Topic: Clinical outcomes and prognostic determinants in relapsed Ewing sarcoma.
Overview
Field of Expertise
Languages Spoken
Awards & Achievements
Talks & Publications
- English
- Hindi
- Bengali
Dr. Debdeep Samaddar is an esteemed consultant at the Department of Medical Oncology at Manipal Hospital EM Bypass, Kolkata. With a distinguished academic background of MBBS from College of Medicine and Sagar Dutta Hospital, Kolkata, MD in Radiation Oncology from R.G. Kar Medical College and Hospital, Kolkata, and DM in Medical Oncology from Tata Memorial Hospital, Mumbai, Dr. Debdeep Samaddar’s clinical practice focuses on evidence-based oncology care, personalised treatment planning, and a multidisciplinary approach for the comprehensive management of cancer.
Over the course of his practice, Dr. Debdeep Samaddar has remained associated with reputed medical establishments across the country, which further strengthened his skill set in cancer diagnosis, treatment and management through structured and compassionate cancer care for patients across different stages of the disease. He specialises in the treatment and management of a wide spectrum of cancers in sub-specialities encompassing Hemato-Oncology, GI Oncology, Breast Oncology, Uro Oncology, Thoracic Oncology, and Bone & Soft Tissue Oncology. His areas of clinical and academic interest include genitourinary malignancies, plasma cell dyscrasias, sarcomas, and immuno-oncology. His dual exposure to medical oncology and radiation oncology helps him contribute effectively through multimodal treatment approaches, which include chemotherapy, immunotherapy, targeted therapy, supportive care, and patient counselling.
Beyond his clinical acumen, Dr. Debdeep Samaddar has a strong interest in oncology research, medical writing, and academic communication. He is dedicated towards contributing to advancements in medical science, and his contributions include multiple peer-reviewed publications, abstracts, poster presentations, and oral presentations at national and international oncology forums. Dr. Samaddar is also passionate about community health education and cancer awareness. Through patient education and counselling, he aims to help people understand warning symptoms, risk factors, screening importance, available treatment options, and the value of regular follow-up.
With a practice representing a balanced combination of advanced oncology training, multidisciplinary care, research orientation, and compassionate patient support, Dr. Debdeep Samaddar aims to provide comprehensive cancer care which aligns with each patient’s medical needs and treatment goals.
- Genitourinary malignancies
- Plasma cell dyscrasias
- Sarcomas
- Breast Oncology
- Immuno-oncology
- Advanced oncology training from Tata Memorial Hospital, Mumbai, one of India’s leading cancer care and research institutes.
- Worked as Medical Oncologist / Ad hoc Assistant Professor at Tata Memorial Hospital, Mumbai from May 2025 to April 2026.
- Experienced in managing a wide range of cancer patients, including solid tumours, blood cancers, genitourinary cancers, plasma cell disorders, sarcomas, and thoracic malignancies.
- Actively participated in multidisciplinary tumour board meetings, contributing to treatment planning and evaluation of complex cancer cases.
- Strong academic orientation in genitourinary malignancies, plasma cell dyscrasias, sarcomas, and immuno-oncology.
- Presented research at national and international oncology conferences, including ESMO Asia, International Myeloma Society Annual Conference, Indian Myeloma Congress, ICON, and ESMO Rare Tumor and Sarcoma Congress.
- Contributed to real-world and retrospective oncology outcomes research, with multiple abstracts, posters, mini oral presentations, and peer-reviewed publications.
- Completed Clinical Research Methods and Protocol Development Workshop – AAZPIRE 2024, Mumbai.
- Completed ACLS and BLS workshop at ACTREC, Mumbai.
- Incidence and clinical profile of brain metastasis treated with whole brain radiotherapy in a tertiary hospital in eastern India: A retrospective audit, Indian Journal of Cancer, 2023.
- Is active surveillance a good treatment option for stage 1 seminoma in a developing nation? Long-term outcomes from the Indian subcontinent eCancer, 2025.
- Perception of Oncology Evaluated by Medical Students — P.O.E.M.S.: A Single Institutional Study Journal of Cancer Education, 2022.
- Genomic Profiling of Driver Gene Alterations in Patients With Non-Small Cell Lung Cancer, Patterns of Treatment and Impact on Survival Outcomes: A Single Centre Experience of More Than 1200 Patients, Clinical Lung Cancer, 2025.
- Docetaxel-oxaliplatin-capecitabine/5-fluorouracil followed by docetaxel versus oxaliplatin-capecitabine/5-fluorouracil in HER2-negative advanced gastric cancers, JNCI Cancer Spectrum, 2024.
- The utility of tumour markers in detecting relapses in testicular seminoma: largest experience from a comprehensive cancer centre in India.
- Annals of Oncology, 2024.
- Clinical profile, treatment patterns, outcomes and predictors of survival in AL amyloidosis: A retrospective study from a tertiary cancer centre, Clinical Lymphoma Myeloma Leukaemia, 2025.
- Clinical outcomes and prognostic determinants in relapsed Ewing sarcoma: Real-world experience from Indian subcontinent ESMO Rare Cancers. Poster presentation at ESMO Asia 2024, Singapore
- Topic: The utility of tumour markers in detecting relapses in testicular seminoma.
- Poster presentation at International Myeloma Society Annual Conference 2025, Toronto, Canada
- Topic: Clinical profile, treatment patterns, outcomes and predictors of survival in AL amyloidosis.
- Mini Oral Presentation at Indian Myeloma Congress 2025, Kolkata
- Topic: Clinical profile and outcome of primary refractory disease in multiple myeloma.
- Mini Oral Presentation at ICON 2024, Mumbai
- Topic: Incidence, treatment pattern and clinical outcomes of acute myeloid leukaemia patients.
- Mini Oral Presentation at Indian Myeloma Congress 2026, Kochi
- Topic: Correlation of haematological response with outcome in AL amyloidosis.
- Poster presentation at ESMO Rare Tumor and Sarcoma Congress 2026, Lugano, Switzerland
- Topic: Clinical outcomes and prognostic determinants in relapsed Ewing sarcoma.
Languages Spoken
Overview
Field of Expertise
Awards & Achievements
Talks & Publications
- Genitourinary malignancies
- Plasma cell dyscrasias
- Sarcomas
- Breast Oncology
- Immuno-oncology
- English
- Hindi
- Bengali
- Advanced oncology training from Tata Memorial Hospital, Mumbai, one of India’s leading cancer care and research institutes.
- Worked as Medical Oncologist / Ad hoc Assistant Professor at Tata Memorial Hospital, Mumbai from May 2025 to April 2026.
- Experienced in managing a wide range of cancer patients, including solid tumours, blood cancers, genitourinary cancers, plasma cell disorders, sarcomas, and thoracic malignancies.
- Actively participated in multidisciplinary tumour board meetings, contributing to treatment planning and evaluation of complex cancer cases.
- Strong academic orientation in genitourinary malignancies, plasma cell dyscrasias, sarcomas, and immuno-oncology.
- Presented research at national and international oncology conferences, including ESMO Asia, International Myeloma Society Annual Conference, Indian Myeloma Congress, ICON, and ESMO Rare Tumor and Sarcoma Congress.
- Contributed to real-world and retrospective oncology outcomes research, with multiple abstracts, posters, mini oral presentations, and peer-reviewed publications.
- Completed Clinical Research Methods and Protocol Development Workshop – AAZPIRE 2024, Mumbai.
- Completed ACLS and BLS workshop at ACTREC, Mumbai.
- Incidence and clinical profile of brain metastasis treated with whole brain radiotherapy in a tertiary hospital in eastern India: A retrospective audit, Indian Journal of Cancer, 2023.
- Is active surveillance a good treatment option for stage 1 seminoma in a developing nation? Long-term outcomes from the Indian subcontinent eCancer, 2025.
- Perception of Oncology Evaluated by Medical Students — P.O.E.M.S.: A Single Institutional Study Journal of Cancer Education, 2022.
- Genomic Profiling of Driver Gene Alterations in Patients With Non-Small Cell Lung Cancer, Patterns of Treatment and Impact on Survival Outcomes: A Single Centre Experience of More Than 1200 Patients, Clinical Lung Cancer, 2025.
- Docetaxel-oxaliplatin-capecitabine/5-fluorouracil followed by docetaxel versus oxaliplatin-capecitabine/5-fluorouracil in HER2-negative advanced gastric cancers, JNCI Cancer Spectrum, 2024.
- The utility of tumour markers in detecting relapses in testicular seminoma: largest experience from a comprehensive cancer centre in India.
- Annals of Oncology, 2024.
- Clinical profile, treatment patterns, outcomes and predictors of survival in AL amyloidosis: A retrospective study from a tertiary cancer centre, Clinical Lymphoma Myeloma Leukaemia, 2025.
- Clinical outcomes and prognostic determinants in relapsed Ewing sarcoma: Real-world experience from Indian subcontinent ESMO Rare Cancers. Poster presentation at ESMO Asia 2024, Singapore
- Topic: The utility of tumour markers in detecting relapses in testicular seminoma.
- Poster presentation at International Myeloma Society Annual Conference 2025, Toronto, Canada
- Topic: Clinical profile, treatment patterns, outcomes and predictors of survival in AL amyloidosis.
- Mini Oral Presentation at Indian Myeloma Congress 2025, Kolkata
- Topic: Clinical profile and outcome of primary refractory disease in multiple myeloma.
- Mini Oral Presentation at ICON 2024, Mumbai
- Topic: Incidence, treatment pattern and clinical outcomes of acute myeloid leukaemia patients.
- Mini Oral Presentation at Indian Myeloma Congress 2026, Kochi
- Topic: Correlation of haematological response with outcome in AL amyloidosis.
- Poster presentation at ESMO Rare Tumor and Sarcoma Congress 2026, Lugano, Switzerland
- Topic: Clinical outcomes and prognostic determinants in relapsed Ewing sarcoma.
Dr. Debdeep Samaddar is an esteemed consultant at the Department of Medical Oncology at Manipal Hospital EM Bypass, Kolkata. With a distinguished academic background of MBBS from College of Medicine and Sagar Dutta Hospital, Kolkata, MD in Radiation Oncology from R.G. Kar Medical College and Hospital, Kolkata, and DM in Medical Oncology from Tata Memorial Hospital, Mumbai, Dr. Debdeep Samaddar’s clinical practice focuses on evidence-based oncology care, personalised treatment planning, and a multidisciplinary approach for the comprehensive management of cancer.
Over the course of his practice, Dr. Debdeep Samaddar has remained associated with reputed medical establishments across the country, which further strengthened his skill set in cancer diagnosis, treatment and management through structured and compassionate cancer care for patients across different stages of the disease. He specialises in the treatment and management of a wide spectrum of cancers in sub-specialities encompassing Hemato-Oncology, GI Oncology, Breast Oncology, Uro Oncology, Thoracic Oncology, and Bone & Soft Tissue Oncology. His areas of clinical and academic interest include genitourinary malignancies, plasma cell dyscrasias, sarcomas, and immuno-oncology. His dual exposure to medical oncology and radiation oncology helps him contribute effectively through multimodal treatment approaches, which include chemotherapy, immunotherapy, targeted therapy, supportive care, and patient counselling.
Beyond his clinical acumen, Dr. Debdeep Samaddar has a strong interest in oncology research, medical writing, and academic communication. He is dedicated towards contributing to advancements in medical science, and his contributions include multiple peer-reviewed publications, abstracts, poster presentations, and oral presentations at national and international oncology forums. Dr. Samaddar is also passionate about community health education and cancer awareness. Through patient education and counselling, he aims to help people understand warning symptoms, risk factors, screening importance, available treatment options, and the value of regular follow-up.
With a practice representing a balanced combination of advanced oncology training, multidisciplinary care, research orientation, and compassionate patient support, Dr. Debdeep Samaddar aims to provide comprehensive cancer care which aligns with each patient’s medical needs and treatment goals.
Field of Expertise
Languages Spoken
Awards & Achievements
Talks & Publications
Overview
- Advanced oncology training from Tata Memorial Hospital, Mumbai, one of India’s leading cancer care and research institutes.
- Worked as Medical Oncologist / Ad hoc Assistant Professor at Tata Memorial Hospital, Mumbai from May 2025 to April 2026.
- Experienced in managing a wide range of cancer patients, including solid tumours, blood cancers, genitourinary cancers, plasma cell disorders, sarcomas, and thoracic malignancies.
- Actively participated in multidisciplinary tumour board meetings, contributing to treatment planning and evaluation of complex cancer cases.
- Strong academic orientation in genitourinary malignancies, plasma cell dyscrasias, sarcomas, and immuno-oncology.
- Presented research at national and international oncology conferences, including ESMO Asia, International Myeloma Society Annual Conference, Indian Myeloma Congress, ICON, and ESMO Rare Tumor and Sarcoma Congress.
- Contributed to real-world and retrospective oncology outcomes research, with multiple abstracts, posters, mini oral presentations, and peer-reviewed publications.
- Completed Clinical Research Methods and Protocol Development Workshop – AAZPIRE 2024, Mumbai.
- Completed ACLS and BLS workshop at ACTREC, Mumbai.
- Genitourinary malignancies
- Plasma cell dyscrasias
- Sarcomas
- Breast Oncology
- Immuno-oncology
- English
- Hindi
- Bengali
- Incidence and clinical profile of brain metastasis treated with whole brain radiotherapy in a tertiary hospital in eastern India: A retrospective audit, Indian Journal of Cancer, 2023.
- Is active surveillance a good treatment option for stage 1 seminoma in a developing nation? Long-term outcomes from the Indian subcontinent eCancer, 2025.
- Perception of Oncology Evaluated by Medical Students — P.O.E.M.S.: A Single Institutional Study Journal of Cancer Education, 2022.
- Genomic Profiling of Driver Gene Alterations in Patients With Non-Small Cell Lung Cancer, Patterns of Treatment and Impact on Survival Outcomes: A Single Centre Experience of More Than 1200 Patients, Clinical Lung Cancer, 2025.
- Docetaxel-oxaliplatin-capecitabine/5-fluorouracil followed by docetaxel versus oxaliplatin-capecitabine/5-fluorouracil in HER2-negative advanced gastric cancers, JNCI Cancer Spectrum, 2024.
- The utility of tumour markers in detecting relapses in testicular seminoma: largest experience from a comprehensive cancer centre in India.
- Annals of Oncology, 2024.
- Clinical profile, treatment patterns, outcomes and predictors of survival in AL amyloidosis: A retrospective study from a tertiary cancer centre, Clinical Lymphoma Myeloma Leukaemia, 2025.
- Clinical outcomes and prognostic determinants in relapsed Ewing sarcoma: Real-world experience from Indian subcontinent ESMO Rare Cancers. Poster presentation at ESMO Asia 2024, Singapore
- Topic: The utility of tumour markers in detecting relapses in testicular seminoma.
- Poster presentation at International Myeloma Society Annual Conference 2025, Toronto, Canada
- Topic: Clinical profile, treatment patterns, outcomes and predictors of survival in AL amyloidosis.
- Mini Oral Presentation at Indian Myeloma Congress 2025, Kolkata
- Topic: Clinical profile and outcome of primary refractory disease in multiple myeloma.
- Mini Oral Presentation at ICON 2024, Mumbai
- Topic: Incidence, treatment pattern and clinical outcomes of acute myeloid leukaemia patients.
- Mini Oral Presentation at Indian Myeloma Congress 2026, Kochi
- Topic: Correlation of haematological response with outcome in AL amyloidosis.
- Poster presentation at ESMO Rare Tumor and Sarcoma Congress 2026, Lugano, Switzerland
- Topic: Clinical outcomes and prognostic determinants in relapsed Ewing sarcoma.
Dr. Debdeep Samaddar is an esteemed consultant at the Department of Medical Oncology at Manipal Hospital EM Bypass, Kolkata. With a distinguished academic background of MBBS from College of Medicine and Sagar Dutta Hospital, Kolkata, MD in Radiation Oncology from R.G. Kar Medical College and Hospital, Kolkata, and DM in Medical Oncology from Tata Memorial Hospital, Mumbai, Dr. Debdeep Samaddar’s clinical practice focuses on evidence-based oncology care, personalised treatment planning, and a multidisciplinary approach for the comprehensive management of cancer.
Over the course of his practice, Dr. Debdeep Samaddar has remained associated with reputed medical establishments across the country, which further strengthened his skill set in cancer diagnosis, treatment and management through structured and compassionate cancer care for patients across different stages of the disease. He specialises in the treatment and management of a wide spectrum of cancers in sub-specialities encompassing Hemato-Oncology, GI Oncology, Breast Oncology, Uro Oncology, Thoracic Oncology, and Bone & Soft Tissue Oncology. His areas of clinical and academic interest include genitourinary malignancies, plasma cell dyscrasias, sarcomas, and immuno-oncology. His dual exposure to medical oncology and radiation oncology helps him contribute effectively through multimodal treatment approaches, which include chemotherapy, immunotherapy, targeted therapy, supportive care, and patient counselling.
Beyond his clinical acumen, Dr. Debdeep Samaddar has a strong interest in oncology research, medical writing, and academic communication. He is dedicated towards contributing to advancements in medical science, and his contributions include multiple peer-reviewed publications, abstracts, poster presentations, and oral presentations at national and international oncology forums. Dr. Samaddar is also passionate about community health education and cancer awareness. Through patient education and counselling, he aims to help people understand warning symptoms, risk factors, screening importance, available treatment options, and the value of regular follow-up.
With a practice representing a balanced combination of advanced oncology training, multidisciplinary care, research orientation, and compassionate patient support, Dr. Debdeep Samaddar aims to provide comprehensive cancer care which aligns with each patient’s medical needs and treatment goals.
Awards & Achievements
Field of Expertise
Languages Spoken
Talks & Publications
Overview
- Incidence and clinical profile of brain metastasis treated with whole brain radiotherapy in a tertiary hospital in eastern India: A retrospective audit, Indian Journal of Cancer, 2023.
- Is active surveillance a good treatment option for stage 1 seminoma in a developing nation? Long-term outcomes from the Indian subcontinent eCancer, 2025.
- Perception of Oncology Evaluated by Medical Students — P.O.E.M.S.: A Single Institutional Study Journal of Cancer Education, 2022.
- Genomic Profiling of Driver Gene Alterations in Patients With Non-Small Cell Lung Cancer, Patterns of Treatment and Impact on Survival Outcomes: A Single Centre Experience of More Than 1200 Patients, Clinical Lung Cancer, 2025.
- Docetaxel-oxaliplatin-capecitabine/5-fluorouracil followed by docetaxel versus oxaliplatin-capecitabine/5-fluorouracil in HER2-negative advanced gastric cancers, JNCI Cancer Spectrum, 2024.
- The utility of tumour markers in detecting relapses in testicular seminoma: largest experience from a comprehensive cancer centre in India.
- Annals of Oncology, 2024.
- Clinical profile, treatment patterns, outcomes and predictors of survival in AL amyloidosis: A retrospective study from a tertiary cancer centre, Clinical Lymphoma Myeloma Leukaemia, 2025.
- Clinical outcomes and prognostic determinants in relapsed Ewing sarcoma: Real-world experience from Indian subcontinent ESMO Rare Cancers. Poster presentation at ESMO Asia 2024, Singapore
- Topic: The utility of tumour markers in detecting relapses in testicular seminoma.
- Poster presentation at International Myeloma Society Annual Conference 2025, Toronto, Canada
- Topic: Clinical profile, treatment patterns, outcomes and predictors of survival in AL amyloidosis.
- Mini Oral Presentation at Indian Myeloma Congress 2025, Kolkata
- Topic: Clinical profile and outcome of primary refractory disease in multiple myeloma.
- Mini Oral Presentation at ICON 2024, Mumbai
- Topic: Incidence, treatment pattern and clinical outcomes of acute myeloid leukaemia patients.
- Mini Oral Presentation at Indian Myeloma Congress 2026, Kochi
- Topic: Correlation of haematological response with outcome in AL amyloidosis.
- Poster presentation at ESMO Rare Tumor and Sarcoma Congress 2026, Lugano, Switzerland
- Topic: Clinical outcomes and prognostic determinants in relapsed Ewing sarcoma.
Dr. Debdeep Samaddar is an esteemed consultant at the Department of Medical Oncology at Manipal Hospital EM Bypass, Kolkata. With a distinguished academic background of MBBS from College of Medicine and Sagar Dutta Hospital, Kolkata, MD in Radiation Oncology from R.G. Kar Medical College and Hospital, Kolkata, and DM in Medical Oncology from Tata Memorial Hospital, Mumbai, Dr. Debdeep Samaddar’s clinical practice focuses on evidence-based oncology care, personalised treatment planning, and a multidisciplinary approach for the comprehensive management of cancer.
Over the course of his practice, Dr. Debdeep Samaddar has remained associated with reputed medical establishments across the country, which further strengthened his skill set in cancer diagnosis, treatment and management through structured and compassionate cancer care for patients across different stages of the disease. He specialises in the treatment and management of a wide spectrum of cancers in sub-specialities encompassing Hemato-Oncology, GI Oncology, Breast Oncology, Uro Oncology, Thoracic Oncology, and Bone & Soft Tissue Oncology. His areas of clinical and academic interest include genitourinary malignancies, plasma cell dyscrasias, sarcomas, and immuno-oncology. His dual exposure to medical oncology and radiation oncology helps him contribute effectively through multimodal treatment approaches, which include chemotherapy, immunotherapy, targeted therapy, supportive care, and patient counselling.
Beyond his clinical acumen, Dr. Debdeep Samaddar has a strong interest in oncology research, medical writing, and academic communication. He is dedicated towards contributing to advancements in medical science, and his contributions include multiple peer-reviewed publications, abstracts, poster presentations, and oral presentations at national and international oncology forums. Dr. Samaddar is also passionate about community health education and cancer awareness. Through patient education and counselling, he aims to help people understand warning symptoms, risk factors, screening importance, available treatment options, and the value of regular follow-up.
With a practice representing a balanced combination of advanced oncology training, multidisciplinary care, research orientation, and compassionate patient support, Dr. Debdeep Samaddar aims to provide comprehensive cancer care which aligns with each patient’s medical needs and treatment goals.
- Genitourinary malignancies
- Plasma cell dyscrasias
- Sarcomas
- Breast Oncology
- Immuno-oncology
- English
- Hindi
- Bengali
- Advanced oncology training from Tata Memorial Hospital, Mumbai, one of India’s leading cancer care and research institutes.
- Worked as Medical Oncologist / Ad hoc Assistant Professor at Tata Memorial Hospital, Mumbai from May 2025 to April 2026.
- Experienced in managing a wide range of cancer patients, including solid tumours, blood cancers, genitourinary cancers, plasma cell disorders, sarcomas, and thoracic malignancies.
- Actively participated in multidisciplinary tumour board meetings, contributing to treatment planning and evaluation of complex cancer cases.
- Strong academic orientation in genitourinary malignancies, plasma cell dyscrasias, sarcomas, and immuno-oncology.
- Presented research at national and international oncology conferences, including ESMO Asia, International Myeloma Society Annual Conference, Indian Myeloma Congress, ICON, and ESMO Rare Tumor and Sarcoma Congress.
- Contributed to real-world and retrospective oncology outcomes research, with multiple abstracts, posters, mini oral presentations, and peer-reviewed publications.
- Completed Clinical Research Methods and Protocol Development Workshop – AAZPIRE 2024, Mumbai.
- Completed ACLS and BLS workshop at ACTREC, Mumbai.
Talks & Publications
Overview
Field of Expertise
Languages Spoken
Awards & Achievements
FAQ's
Patients visit Dr. Debdeep Samaddar, a leading Consultant - Medical Oncology at Manipal Hospitals EM Bypass - Kolkata, for expert care and advanced treatments. Known for accurate diagnoses and patient centric care, Dr. Debdeep Samaddar is a trusted choice for exceptional medical support.
Dr. Debdeep Samaddar Specialises in:
- Genitourinary malignancies
- Plasma cell dyscrasias
- Sarcomas
- Breast Oncology
- Immuno-oncology
To book an appointment with Dr. Debdeep Samaddar at Manipal Hospitals EM Bypass - Kolkata, please call 033 6907 0001 / 033 6907 0000. Our dedicated team will assist you in scheduling a convenient time for your consultation.
Dr. Debdeep Samaddar has extensive experience and qualifications in Medical Oncology at Manipal Hospitals EM Bypass - Kolkata. With expertise spanning MBBS . MD . DM (Medical Oncology- TMH Mumbai), bringing a wealth of knowledge and skill to their practice, ensuring top-notch patient care. Dr. Debdeep Samaddar has also published numerous articles and publications in the field of Medical Oncology.
For your initial appointment with Dr. Debdeep Samaddar, please bring any relevant medical records, including previous imaging scans, laboratory results, and medication lists. It's important to provide a detailed medical history and any pertinent information about your condition. If you have insurance, please bring your insurance card and any necessary referral documents. This will help facilitate a comprehensive evaluation and discussion during your appointment.
Refund Policy
1) Up to 4 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation can be done with full refund of the payment.
2) Up to 2 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation of appointment and refund with a cancellation charge of Rs.100/-.
3) Less than 2 hrs of appointment time:
Rescheduling / cancellation of appointment cannot be done, payment non-refundable in this case. However, Units can have the discretion to refund / reschedule in case of exigencies.
Please note : While making the payment online, above mentioned payment terms and conditions should be agreed upon by customers, by clicking in a box ( I agree) and then proceed for payment.
PATIENT CONSENT FOR TELEMEDICINE / TELECONSULTATION
Telemedicine involves the use of electronic communications to enable Hospitals/health care centres to provide healthcare services at different locations through exchange of information and for the purpose of improving patient care. I, confirm that I have received the necessary information to sign this form and I agree to take part in a live telemedicine/teleconsultation session with Manipal Hospitals.
I understand that:
- Interactive audio/video connection, electronic information and communication technologies shall be used for providing me with a telemedicine/teleconsultation.
- In case the information obtained via teleconsultation is not sufficient to make a diagnosis, I may be required to go to Manipal Hospitals for in-person consultation.
- Though the telemedicine/teleconsultation is private, other individuals, medical and non-medical, may be present to facilitate the consultation and that they will take reasonable steps to maintain confidentiality of the information obtained.
- A limited visual examination will take place during the telemedicine/teleconsultation and that it cannot replace a full medical examination done physically at Manipal Hospitals.
- I have the right to withhold or withdraw my consent to the use of telemedicine/teleconsultation in the course of my care at any time, without affecting my right to future care or treatment. I may also revoke my consent orally or in writing at any time.
- I may be prescribed medicines for treatment or/and diagnostic tests to further evaluate my health condition. All prescription will be sent to my registered email/phone no. Manipal Hospitals will keep a record of the consultation & prescription in my medical record.
- The telemedicine/teleconsultation services are not in any way intended to be used in case of an emergency.
- There can be potential risks with this technology e.g information transmitted may not be sufficient to allow for appropriate medical decision, the video /audio may disconnect/stop in-between, security protocols could fail causing a breach of privacy of personal medical information.
- Any relevant medical information about me including details of my medical history, examinations, x-rays, tests, photographs or other images may be transmitted /shared by Manipal Hospitals with their staff, specialist, business partners for the purpose of record, communications, feedback, enquires, follow ups, analysis etc.
- Manipal Hospitals responsibility shall terminate upon conclusion of this teleconference.
- I hereby consent that in consideration for the telemedicine / teleconsultation services rendered to me, I agree to pay the relevant charges.
- I hereby release Manipal Hospitals, its personnel and any other person participating in my care from any and all liability which may arise from authorized use of such Video / E-Consultation, Videotapes, Digital recording films and Photographs. I have read this document and understand the risk of the telemedicine / teleconsultation.
- I hereby consent to participate in a telemedicine / teleconsultation under the terms & conditions described in this document.
You’re on Our Indian Website
Visit the Global site for International patient services
'Click' to chat with us
